Prime Medicine, Inc.

NASDAQ (USD): Prime Medicine, Inc. (PRME)

Last Price

2.90

Today's Change

+0.11 (3.94%)

Day's Change

2.73 - 3.05

Trading Volume

1,759,859

Overview

Market Cap

380 Million

Shares Outstanding

131 Million

Avg Volume

1,746,723

Avg Price (50 Days)

3.60

Avg Price (200 Days)

5.00

PE Ratio

-1.41

EPS

-2.06

Earnings Announcement

06-Mar-2025

Previous Close

2.79

Open

2.76

Day's Range

2.73 - 3.05

Year Range

2.56 - 9.8

Trading Volume

2,315,230

Price Change Highlight

1 Day Change

3.94%

5 Day Change

-0.34%

1 Month Change

-2.36%

3 Month Change

-24.28%

6 Month Change

-51.59%

Ytd Change

-66.89%

1 Year Change

-66.89%

3 Year Change

-81.13%

5 Year Change

-81.13%

10 Year Change

-81.13%

Max Change

-81.13%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment